Speaker illustration

Doctor Angelos Liontos

University hospital of Ioannina, Ioannina (Greece)

Member of:

European Society of Cardiology

Alternations in markers of insulin resistance: HOMA-IR, HOMA-B, QUICKI, after dual therapy combination with telmisartan/amlodipine in prediabetic hypertensive patients

Event: ESC Preventive Cardiology 2022

Topic: Pharmacotherapy

Session: ePosters

Thumbnail

Changes in TRG/ApoA-1 ratio, TRG/HDL-C ratio and lipid serum profile after combination therapy with manidipine/delapril in prediabetic hypertensive patients

Event: ESC Preventive Cardiology 2022

Topic: Pharmacotherapy

Session: ePosters

Thumbnail

Changes in TRG/ApoA-1 ratio, TRG/HDL-C ratio and lipid serum profile after combination therapy with telmisartan/amlodipine in prediabetic patients

Event: ESC Preventive Cardiology 2022

Topic: Pharmacotherapy

Session: ePosters

Thumbnail

Changes in TRG/ApoA-1 ratio, TRG/HDL-C ratio and lipid serum profile after combination therapy with valsartan/amlodipine in prediabetic patients

Event: ESC Preventive Cardiology 2022

Topic: Pharmacotherapy

Session: ePosters

Thumbnail

Alternations in markers of insulin resistance: HOMA-IR, HOMA-B, QUICKI, after dual therapy combination with delapril/manidipine in prediabetic hypertensive patients

Event: ESC Preventive Cardiology 2022

Topic: Pharmacotherapy

Session: ePosters

Thumbnail

Alternations in markers of insulin resistance: HOMA-IR, HOMA-B, QUICKI, after dual therapy combination with valsartan/amlodipine in prediabetic hypertensive patients

Event: ESC Preventive Cardiology 2022

Topic: Pharmacotherapy

Session: ePosters

Thumbnail

This platform is supported by

logo Novo Nordisk